187 related articles for article (PubMed ID: 1863470)
1. Expression in yeast of a cDNA clone encoding a transmembrane glycoprotein gp41 fragment (a.a. 591-642) bearing the major immunodominant domain of human immunodeficiency virus.
Gairin JE; Madaule P; Traincard F; Barrès E; Rossier J
FEMS Microbiol Immunol; 1991 Apr; 3(2):109-19. PubMed ID: 1863470
[TBL] [Abstract][Full Text] [Related]
2. A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1.
Madaule P; Gairin JE; Bénichou S; Rossier J
FEMS Microbiol Immunol; 1991 Apr; 3(2):99-107. PubMed ID: 1713777
[TBL] [Abstract][Full Text] [Related]
3. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
[TBL] [Abstract][Full Text] [Related]
4. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV.
Mitchell WM; Ding L; Gabriel J
AIDS; 1998 Jan; 12(2):147-56. PubMed ID: 9468363
[TBL] [Abstract][Full Text] [Related]
6. Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detection.
Eberle J; Loussert-Ajaka I; Brust S; Zekeng L; Hauser PH; Kaptue L; Knapp S; Damond F; Saragosti S; Simon F; Gürtler LG
J Virol Methods; 1997 Aug; 67(1):85-91. PubMed ID: 9274821
[TBL] [Abstract][Full Text] [Related]
7. Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection.
Dorn J; Masciotra S; Yang C; Downing R; Biryahwaho B; Mastro TD; Nkengasong J; Pieniazek D; Rayfield MA; Hu DJ; Lal RB
J Clin Microbiol; 2000 Feb; 38(2):773-80. PubMed ID: 10655384
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
[TBL] [Abstract][Full Text] [Related]
9. Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160.
Benjouad A; Gluckman JC; Montagnier L; Bahraoui E
J Virol; 1993 Mar; 67(3):1693-7. PubMed ID: 7679751
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus.
McLain L; Porta C; Lomonossoff GP; Durrani Z; Dimmock NJ
AIDS Res Hum Retroviruses; 1995 Mar; 11(3):327-34. PubMed ID: 7786579
[TBL] [Abstract][Full Text] [Related]
11. Antigenic properties of phage displayed peptides comprising disulfide-bonded loop of the immunodominant region of HIV-1 gp41.
Cano A; Viveros M; Acero G; Govezensky T; Munguia ME; Gonzalez E; Soto L; Gevorkian G; Manoutcharian K
Immunol Lett; 2004 Sep; 95(2):207-12. PubMed ID: 15388262
[TBL] [Abstract][Full Text] [Related]
12. Characterization of monoclonal antibodies to human immunodeficiency virus type 1 gp41 by HIV-1 polypeptides expressed in Escherichia coli.
Larcher C; Bröker M; Huemer HP; Sölder B; Schulz TF; Hofbauer JM; Wachter H; Dierich MP
FEMS Microbiol Immunol; 1990 Sep; 2(2):103-10. PubMed ID: 1701654
[TBL] [Abstract][Full Text] [Related]
13. Recombinant multi-epitope vaccine induce predefined epitope-specific antibodies against HIV-1.
Li H; Liu ZQ; Ding J; Chen YH
Immunol Lett; 2002 Nov; 84(2):153-7. PubMed ID: 12270553
[TBL] [Abstract][Full Text] [Related]
14. Interaction between a Fab fragment against gp41 of human immunodeficiency virus 1 and its peptide epitope: characterization using a peptide epitope library and molecular modeling.
Stigler RD; Rüker F; Katinger D; Elliott G; Höhne W; Henklein P; Ho JX; Keeling K; Carter DC; Nugel E
Protein Eng; 1995 May; 8(5):471-9. PubMed ID: 8532669
[TBL] [Abstract][Full Text] [Related]
15. Molecular approaches to AIDS vaccine development using baculovirus expression vectors.
Kang CY
Methods Mol Biol; 1995; 39():295-315. PubMed ID: 7542523
[No Abstract] [Full Text] [Related]
16. Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody.
Bugge TH; Lindhardt BO; Hansen LL; Kusk P; Hulgaard E; Holmbäck K; Klasse PJ; Zeuthen J; Ulrich K
J Virol; 1990 Sep; 64(9):4123-9. PubMed ID: 1696634
[TBL] [Abstract][Full Text] [Related]
17. Group o human immunodeficiency virus type 1 infection that escaped detection in two immmunoassays.
Zouhair S; Roussin-Bretagne S; Moreau A; Brunet S; Laperche S; Maniez M; Barin F; Harzic M
J Clin Microbiol; 2006 Feb; 44(2):662-5. PubMed ID: 16455942
[TBL] [Abstract][Full Text] [Related]
18. Expression of HIV-2 Gag and Env antigens in E. coli.
Ulrich R; Siakkou H; Krüger DH
Acta Virol; 1992 Oct; 36(5):491. PubMed ID: 1364028
[No Abstract] [Full Text] [Related]
19. Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus.
McLain L; Durrani Z; Wisniewski LA; Porta C; Lomonossoff GP; Dimmock NJ
Vaccine; 1996 Jun; 14(8):799-810. PubMed ID: 8817828
[TBL] [Abstract][Full Text] [Related]
20. Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro.
Robinson WE; Kawamura T; Gorny MK; Lake D; Xu JY; Matsumoto Y; Sugano T; Masuho Y; Mitchell WM; Hersh E
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3185-9. PubMed ID: 2326277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
